Cargando…

The Real Role of β-Blockers in Daily Cardiovascular Therapy

The role of β-adrenoceptor antagonists (β-blockers) in cardiovascular therapy has been subject to diverse trends and changes over the decades. With the advent of a wide variety of excellent drugs for the treatment of antihypertension, β-blockers have been relegated from the first-line treatment of e...

Descripción completa

Detalles Bibliográficos
Autores principales: Dézsi, Csaba András, Szentes, Veronika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591796/
https://www.ncbi.nlm.nih.gov/pubmed/28357786
http://dx.doi.org/10.1007/s40256-017-0221-8
_version_ 1783262780788310016
author Dézsi, Csaba András
Szentes, Veronika
author_facet Dézsi, Csaba András
Szentes, Veronika
author_sort Dézsi, Csaba András
collection PubMed
description The role of β-adrenoceptor antagonists (β-blockers) in cardiovascular therapy has been subject to diverse trends and changes over the decades. With the advent of a wide variety of excellent drugs for the treatment of antihypertension, β-blockers have been relegated from the first-line treatment of essential hypertension. However, they remain the drugs of first choice in recommendations from the respective medical societies for heart failure, coronary artery disease, and atrial fibrillation as well as in hypertension complicated with heart failure, angina pectoris, or prior myocardial infarction. When indicated, cardioselective β-blockers should be prescribed in patients with diabetes mellitus or chronic obstructive pulmonary disease. We review the available evidence for the use of β-blockers in clinical conditions in which recommendations can be made for everyday practice.
format Online
Article
Text
id pubmed-5591796
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-55917962017-09-25 The Real Role of β-Blockers in Daily Cardiovascular Therapy Dézsi, Csaba András Szentes, Veronika Am J Cardiovasc Drugs Review Article The role of β-adrenoceptor antagonists (β-blockers) in cardiovascular therapy has been subject to diverse trends and changes over the decades. With the advent of a wide variety of excellent drugs for the treatment of antihypertension, β-blockers have been relegated from the first-line treatment of essential hypertension. However, they remain the drugs of first choice in recommendations from the respective medical societies for heart failure, coronary artery disease, and atrial fibrillation as well as in hypertension complicated with heart failure, angina pectoris, or prior myocardial infarction. When indicated, cardioselective β-blockers should be prescribed in patients with diabetes mellitus or chronic obstructive pulmonary disease. We review the available evidence for the use of β-blockers in clinical conditions in which recommendations can be made for everyday practice. Springer International Publishing 2017-03-29 2017 /pmc/articles/PMC5591796/ /pubmed/28357786 http://dx.doi.org/10.1007/s40256-017-0221-8 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Review Article
Dézsi, Csaba András
Szentes, Veronika
The Real Role of β-Blockers in Daily Cardiovascular Therapy
title The Real Role of β-Blockers in Daily Cardiovascular Therapy
title_full The Real Role of β-Blockers in Daily Cardiovascular Therapy
title_fullStr The Real Role of β-Blockers in Daily Cardiovascular Therapy
title_full_unstemmed The Real Role of β-Blockers in Daily Cardiovascular Therapy
title_short The Real Role of β-Blockers in Daily Cardiovascular Therapy
title_sort real role of β-blockers in daily cardiovascular therapy
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5591796/
https://www.ncbi.nlm.nih.gov/pubmed/28357786
http://dx.doi.org/10.1007/s40256-017-0221-8
work_keys_str_mv AT dezsicsabaandras therealroleofbblockersindailycardiovasculartherapy
AT szentesveronika therealroleofbblockersindailycardiovasculartherapy
AT dezsicsabaandras realroleofbblockersindailycardiovasculartherapy
AT szentesveronika realroleofbblockersindailycardiovasculartherapy